Maximus (NYSE:MMS) Sets New 1-Year Low – Time to Sell?

Posted by Francis Steltz on Jun 30th, 2026

Maximus, Inc. (NYSE:MMS – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $52.73 and last traded at $53.3310, with a volume of 272952 shares traded. The stock had previously closed at $54.46.

Analyst Ratings Changes

A number of research analysts have recently issued reports on MMS shares. Wall Street Zen upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Read Our Latest Research Report on Maximus

Maximus Price Performance

The business has a fifty day simple moving average of $61.46 and a 200 day simple moving average of $73.65. The stock has a market capitalization of $2.82 billion, a P/E ratio of 8.02 and a beta of 0.58. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87.

Maximus (NYSE:MMS – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same period last year, the business earned $2.01 EPS. The business’s revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, analysts expect that Maximus, Inc. will post 8.43 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Friday, May 15th. Maximus’s payout ratio is presently 19.76%.

Hedge Funds Weigh In On Maximus

Several institutional investors have recently bought and sold shares of the company. Royal Bank of Canada raised its stake in shares of Maximus by 146.2% in the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock valued at $1,345,000 after buying an additional 11,716 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after purchasing an additional 221 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Maximus by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after purchasing an additional 11,754 shares in the last quarter. Jane Street Group LLC increased its stake in shares of Maximus by 941.2% in the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock worth $6,701,000 after purchasing an additional 88,835 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in shares of Maximus in the second quarter valued at approximately $204,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.

About Maximus

(Get Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.